Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Chuanlong Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7901-156X; OpenAlex author ID A5025030643. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Novel poly (ADP-ribose) polymerases inhibitor DHC-1 exhibits in vitro and in vivo anticancer activity on BRCA-deficient pancreatic cancer cells. Last author DOI 10.1016/j.fct.2020.111892↗
  2. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. Co-author DOI 10.1038/s41419-019-2073-4↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaochen Wu · 1 shared paper, 2021 · strength 0.14
  2. Ning Wu · 1 shared paper, 2019 · strength 0.10
  3. Dayong Shi · 1 shared paper, 2019 · strength 0.10
  4. Qi Xu · 1 shared paper, 2019 · strength 0.10
  5. Huaizhi Wang · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.